Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.44M 1.36M 1.24M 2.32M 157M 2.34M 16.34M 6.31M 80.36M 6.16M 6.03M 258M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.15M 6.76M 6.13M 11.52M 780M 11.58M 80.95M 31.26M 398M 30.52M 29.86M 1.28B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
+0.11%+1.71%+63.52%+117.61% 1,056B
+0.27%+0.92%+51.33%+73.35% 655B
+0.73%+0.68%+20.70%+74.90% 471B
-1.34%-3.43%+37.29%+40.39% 342B
-0.25%+4.09%+22.38%+29.14% 277B
+0.58%-0.65%+13.55%+13.40% 257B
+0.85%+6.35%+53.17%+54.39% 226B
+0.85%+1.10%+35.78%+101.82% 189B
+0.05%-2.32%-28.08%-60.74% 170B
Average -10.22%+0.97%+29.96%+49.36% 404.77B
Weighted average by Cap. -0.25%+1.04%+40.33%+69.74%

Financials

2007 2008
Net sales 23.47M 20.64M 19.52M 17.7M 33.24M 2.25B 33.44M 234M 90.25M 1.15B 88.1M 86.19M 3.69B 25.96M 22.83M 21.59M 19.58M 36.78M 2.49B 36.99M 259M 99.84M 1.27B 97.46M 95.35M 4.09B
Net income -20.86M -18.34M -17.35M -15.73M -29.55M -2B -29.72M -208M -80.22M -1.02B -78.31M -76.61M -3.28B -4.01M -3.52M -3.33M -3.02M -5.67M -385M -5.71M -39.89M -15.41M -196M -15.04M -14.71M -631M
Net Debt 18.79M 16.53M 15.63M 14.17M 26.62M 1.8B 26.77M 187M 72.26M 920M 70.55M 69.02M 2.96B 6.49M 5.71M 5.4M 4.89M 9.19M 623M 9.25M 64.61M 24.95M 318M 24.36M 23.83M 1.02B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-